BIOVIE INC.
BIVIdata completeness 63%14 fiscal years on fileData notes: no data for concept 'revenue'; no data for concept 'capex'; no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'depreciationAmortization'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'incomeTaxExpense'; no data for concept 'pretaxIncome'
BIOVIE INC. earns about -311% on equity, and has bought back 71% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | −$26.1M1 | −$50.3M2 | −$32.1M3 | −$17.5M4 | −$22.1M4 |
| Operating cash flow | −$19M5 | −$40.3M6 | −$27.9M7 | −$19M8 | −$19M8 |
| Capital expenditure | — | — | — | — | — |
| Free cash flow (derived) | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $18.6M9 | $19.5M10 | $23.8M11 | $17.5M12 | $8.98M12 |
| Diluted shares | 24.7M | 3.2M | 451,853 | 1.5M | 7.2M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $14.17 of net worth that earned you −$30.46 last year.
It earned an average -311% on equity over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 71% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2022-06-30 · accession 0001520138-23-000325 (NetIncomeLoss)
- 10-K · period ending 2023-06-30 · accession 0001520138-24-000324 (NetIncomeLoss)
- 10-K · period ending 2024-06-30 · accession 0001520138-25-000268 (NetIncomeLoss)
- 10-K · period ending 2025-06-30 · accession 0001520138-26-000332 (NetIncomeLoss)
- 10-K · period ending 2022-06-30 · accession 0001520138-23-000325 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-06-30 · accession 0001520138-24-000324 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-06-30 · accession 0001520138-25-000268 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2025-06-30 · accession 0001520138-26-000332 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-06-30 · accession 0001520138-23-000325 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-06-30 · accession 0001520138-24-000324 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-06-30 · accession 0001520138-25-000268 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2025-06-30 · accession 0001520138-26-000332 (CashAndCashEquivalentsAtCarryingValue)